杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/08/15 | 1,746 | 1,750 | 1,733 | 1,744 | -13 | -0.7% | 113,400 |
| 2023/08/14 | 1,783 | 1,790 | 1,756 | 1,757 | -24 | -1.3% | 69,500 |
| 2023/08/10 | 1,761 | 1,781 | 1,756 | 1,781 | +20 | +1.1% | 54,700 |
| 2023/08/09 | 1,750 | 1,764 | 1,737 | 1,761 | +11 | +0.6% | 49,900 |
| 2023/08/08 | 1,730 | 1,755 | 1,730 | 1,750 | +21 | +1.2% | 63,400 |
| 2023/08/07 | 1,707 | 1,738 | 1,707 | 1,729 | +19 | +1.1% | 57,800 |
| 2023/08/04 | 1,730 | 1,730 | 1,705 | 1,710 | -25 | -1.4% | 112,700 |
| 2023/08/03 | 1,775 | 1,775 | 1,721 | 1,735 | -73 | -4% | 193,600 |
| 2023/08/02 | 1,800 | 1,813 | 1,795 | 1,808 | +6 | +0.3% | 142,700 |
| 2023/08/01 | 1,784 | 1,802 | 1,782 | 1,802 | +29 | +1.6% | 150,000 |
| 2023/07/31 | 1,795 | 1,803 | 1,767 | 1,773 | -7 | -0.4% | 101,100 |
| 2023/07/28 | 1,761 | 1,785 | 1,760 | 1,780 | +3 | +0.2% | 104,000 |
| 2023/07/27 | 1,767 | 1,777 | 1,759 | 1,777 | +1 | +0.1% | 46,900 |
| 2023/07/26 | 1,760 | 1,778 | 1,758 | 1,776 | +12 | +0.7% | 59,200 |
| 2023/07/25 | 1,770 | 1,774 | 1,759 | 1,764 | -6 | -0.3% | 62,700 |
| 2023/07/24 | 1,755 | 1,770 | 1,749 | 1,770 | +19 | +1.1% | 67,000 |
| 2023/07/21 | 1,747 | 1,751 | 1,738 | 1,751 | +16 | +0.9% | 63,700 |
| 2023/07/20 | 1,747 | 1,751 | 1,732 | 1,735 | -14 | -0.8% | 40,400 |
| 2023/07/19 | 1,746 | 1,749 | 1,735 | 1,749 | +16 | +0.9% | 60,800 |
| 2023/07/18 | 1,713 | 1,734 | 1,713 | 1,733 | +16 | +0.9% | 42,400 |
| 2023/07/14 | 1,718 | 1,724 | 1,706 | 1,717 | +3 | +0.2% | 62,900 |
| 2023/07/13 | 1,719 | 1,722 | 1,704 | 1,714 | +1 | +0.1% | 73,900 |
| 2023/07/12 | 1,708 | 1,717 | 1,706 | 1,713 | +10 | +0.6% | 79,600 |
| 2023/07/11 | 1,730 | 1,732 | 1,700 | 1,703 | -16 | -0.9% | 79,400 |
| 2023/07/10 | 1,722 | 1,727 | 1,714 | 1,719 | -3 | -0.2% | 82,200 |
| 2023/07/07 | 1,728 | 1,735 | 1,718 | 1,722 | -6 | -0.3% | 148,900 |
| 2023/07/06 | 1,749 | 1,750 | 1,715 | 1,728 | -20 | -1.1% | 130,100 |
| 2023/07/05 | 1,728 | 1,750 | 1,727 | 1,748 | +16 | +0.9% | 68,400 |
| 2023/07/04 | 1,745 | 1,751 | 1,732 | 1,732 | -29 | -1.6% | 105,300 |
| 2023/07/03 | 1,755 | 1,772 | 1,754 | 1,761 | +10 | +0.6% | 59,800 |
| 2023/06/30 | 1,757 | 1,758 | 1,740 | 1,751 | -5 | -0.3% | 85,500 |
| 2023/06/29 | 1,766 | 1,775 | 1,751 | 1,756 | -11 | -0.6% | 68,800 |
| 2023/06/28 | 1,748 | 1,767 | 1,746 | 1,767 | +19 | +1.1% | 80,900 |
| 2023/06/27 | 1,758 | 1,760 | 1,735 | 1,748 | -20 | -1.1% | 76,900 |
| 2023/06/26 | 1,780 | 1,781 | 1,756 | 1,768 | -5 | -0.3% | 80,200 |
| 2023/06/23 | 1,788 | 1,788 | 1,767 | 1,773 | -11 | -0.6% | 119,700 |
| 2023/06/22 | 1,768 | 1,787 | 1,768 | 1,784 | +16 | +0.9% | 92,600 |
| 2023/06/21 | 1,772 | 1,786 | 1,766 | 1,768 | +4 | +0.2% | 124,000 |
| 2023/06/20 | 1,757 | 1,764 | 1,748 | 1,764 | ±0 | ±0% | 45,400 |
| 2023/06/19 | 1,759 | 1,771 | 1,752 | 1,764 | +7 | +0.4% | 57,400 |
| 2023/06/16 | 1,738 | 1,759 | 1,737 | 1,757 | +16 | +0.9% | 202,700 |
| 2023/06/15 | 1,734 | 1,748 | 1,733 | 1,741 | +3 | +0.2% | 83,200 |
| 2023/06/14 | 1,748 | 1,748 | 1,733 | 1,738 | -8 | -0.5% | 81,900 |
| 2023/06/13 | 1,750 | 1,759 | 1,741 | 1,746 | ±0 | ±0% | 99,200 |
| 2023/06/12 | 1,748 | 1,753 | 1,735 | 1,746 | +7 | +0.4% | 86,600 |
| 2023/06/09 | 1,751 | 1,751 | 1,733 | 1,739 | +2 | +0.1% | 139,300 |
| 2023/06/08 | 1,735 | 1,744 | 1,725 | 1,737 | +10 | +0.6% | 97,300 |
| 2023/06/07 | 1,741 | 1,753 | 1,723 | 1,727 | -19 | -1.1% | 113,500 |
| 2023/06/06 | 1,733 | 1,746 | 1,717 | 1,746 | +9 | +0.5% | 115,400 |
| 2023/06/05 | 1,733 | 1,758 | 1,725 | 1,737 | -36 | -2% | 207,600 |
401～
450
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 143,100円 | +3.2% | +4.5% | 3.63% | 16.44倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| サンバイオ | 162,700円 | - | - | 0.00% | - | 75.36倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 持田薬 | 301,500円 | +3.0% | +27.5% | 2.65% | 19.09倍 | 0.83倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 174,100円 | +21.7% | +999.9% | 0.00% | 7.25倍 | 2.40倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 栄研化 | 213,600円 | +0.4% | -8.4% | 2.48% | 27.42倍 | 1.55倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
